235 related articles for article (PubMed ID: 4462870)
1. Sequential administration of two oncostatic drugs: study of modalities for pharmacodynamic potentiation.
Pouillart R; Huong TH; Brugerie E; Lheritier J
Biomedicine; 1974 Dec; 21(12):471-9. PubMed ID: 4462870
[No Abstract] [Full Text] [Related]
2. [L 1210 leukemia, an experimental model for the potentiation of drugs used for acute leukemias].
Pouillart P; Huong TH; Lhéritier J
Bull Cancer; 1974; 61(4):509-26. PubMed ID: 4458834
[No Abstract] [Full Text] [Related]
3. [Principle products used in chemotherapy. Administration methods].
Boillon C; Olivro A; Lemerle J
Soins; 1979 Aug 5-20; 24(15-16):51-9. PubMed ID: 90390
[No Abstract] [Full Text] [Related]
4. Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules.
Skipper HE; Schabel FM; Mellett LB; Montgomery JA; Wilkoff LJ; Lloyd HH; Brockman RW
Cancer Chemother Rep; 1970 Dec; 54(6):431-50. PubMed ID: 5527023
[No Abstract] [Full Text] [Related]
5. Rationale of chemotherapeutic adjuvant treatment.
Goldin A
Arch Geschwulstforsch; 1978; 48(7):627-35. PubMed ID: 736743
[No Abstract] [Full Text] [Related]
6. Synergistic antileukemic activity of combinations of two nitrosoureas.
Wheeler GP; Schabel FM; Trader MW
Cancer Treat Rep; 1981; 65(7-8):591-9. PubMed ID: 6454482
[TBL] [Abstract][Full Text] [Related]
7. [Effect of combination chemotherapy of nitrosourea MCNU with various anti-tumor agents].
Ninomiya K; Sekido S; Araki T
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1315-23. PubMed ID: 6428326
[TBL] [Abstract][Full Text] [Related]
8. Circadian optimization of the treatment of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine and methylprednisolone.
Burns ER; Scheving LE
Chronobiologia; 1980; 7(1):41-51. PubMed ID: 7438892
[No Abstract] [Full Text] [Related]
9. Combination chemotherapy in sequence for the treatment of L1210 leukemia.
Roberts D; Hilliard SL
Cancer Res; 1978 Aug; 38(8):2317-20. PubMed ID: 667827
[No Abstract] [Full Text] [Related]
10. Single versus combination chemotherapy of L1210 leukemia.
Koza I; Balázová E; Ujházy V
Neoplasma; 1980; 27(6):691-6. PubMed ID: 7254424
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy with 5-FU 1-(aminomethyl)-3-(2-chloroethyl)-3-nitrosourea (ACNU), and mitomycin (FUM) for carcinoma of the pancreas.
Meguro S; Kuraishi Y; Ichiba K; Abe M; Yoda T; Mikouchi S
Cancer Treat Rep; 1982 Aug; 66(8):1645-6. PubMed ID: 6955023
[No Abstract] [Full Text] [Related]
12. Combined chronochemotherapy of L1210 leukemic mice using 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine, methylprednisolone and cis-diamminedichloroplatinum.
Scheving LE; Burns ER; Halberg F; Pauly JE
Chronobiologia; 1980; 7(1):33-40. PubMed ID: 7192203
[TBL] [Abstract][Full Text] [Related]
13. [Effects of combination chemotherapy of MCNU with various anti-cancer agents].
Machida S; Ito Y; Hoshino A
Gan To Kagaku Ryoho; 1985 Feb; 12(2):298-302. PubMed ID: 3918506
[TBL] [Abstract][Full Text] [Related]
14. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
Kim K; Blechman WJ; Riddle VG; Pardee AB
Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy of hormonally unresponsive prostatic carcinoma.
deKernion JB; Lindner A
Urol Clin North Am; 1984 May; 11(2):319-26. PubMed ID: 6233779
[TBL] [Abstract][Full Text] [Related]
16. An improved method for analyzing survival data from combination chemotherapy experiments.
Carter WH; Stablein DM; Wampler GL
Cancer Res; 1979 Sep; 39(9):3446-53. PubMed ID: 476674
[TBL] [Abstract][Full Text] [Related]
17. [Increased cytotoxic effects of various anticancer drugs by alpha-interferon (HLBI) on human tumor xenografts in nude mice].
Nosoh Y; Yoshinaka K; Yamaguchi M; Tani T; Toge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1623-8. PubMed ID: 6433798
[TBL] [Abstract][Full Text] [Related]
18. Factors pertaining to complete drug-induced remission of tumor in animals and man.
Goldin A
Cancer Res; 1969 Dec; 29(12):2285-91. PubMed ID: 4917976
[No Abstract] [Full Text] [Related]
19. Combination therapy: some concepts and results.
Skipper HE
Cancer Chemother Rep 2; 1974 Mar; 4(1):137-45. PubMed ID: 4363649
[No Abstract] [Full Text] [Related]
20. Schedule-dependent synergism of methotrexate and vincristine against murine L1210 leukemia.
Chello PL; Sirotnak FM; Dorick DM; Moccio DM
Cancer Treat Rep; 1979; 63(11-12):1889-94. PubMed ID: 526921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
